… As an exploratory objective, we analyzed the efficacy of gefitinib treatment according to
the EGFR mutation subtypes. Interestingly, in-frame exon 19 deletions were associated with …

… (EGFR) mutations are associated with sensitivity to gefitinib or … EGFR mutations, exon 19
deletions and L858R mutations, and … NSCLC patients after treatment with gefitinib or erlotinib. …

… The aim of this study was to compare the effectiveness of gefitinib, erlotinib, and afatinib.
We retrospectively reviewed the records of 310 patients with the diagnosis of EGFR mutation-…

… icotinib and gefitinib had similar efficacy for brain metastasis of EGFR mutated NSCLC.
Large randomized studies are suggested to further illuminate the effect of these two EGFR-TKIs …

… EGFR mutations.9, 10 However, no clinical study to evaluate efficacy of EGFR-TKIs and
mutation … ASC showing EGFR mutations have been reported with an EGFR mutation frequency …

… EGFR TKI can lead to a good antitumor response. Thus, we evaluated … efficacy of such
chemotherapy after lack of gefitinib response for advanced NSCLC harboring EGFR mutations …

… However, the efficacy of these agents against EGFR wild-type (-… efficacy in patients with
NSCLC whose EGFR mutation status had been confirmed and who all received 250 mg gefitinib …

… the association between BSA and the efficacy of gefitinib monotherapy found in the current
… of gefitinib. This suggests the importance of dose-adjustment by BSA in gefitinib monotherapy…

… predictors of gefitinib efficacy. In the current study, we evaluated the EGFR mutation status
and … to assess their predictive value in regard to the efficacy of gefitinib in this population. …

… therapy according to BSA, based on the results of the present study, the efficacy of gefitinib
therapy does not depend on the BSA of patients with NSCLC harboring an EGFR mutation. …